Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Health Catalyst (DE:2YP)
FRANKFURT:2YP
Health Catalyst (2YP) Stock Price & Analysis
0 Followers
2YP Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€5.15 - €12.70
Previous Close€5.15
Volume0.00
Average Volume (3M)50.00
Market Cap
€306.19M
Enterprise Value€241.82M
Total Cash (Recent Filing)$317.73M
Total Debt (Recent Filing)$249.07M
Price to Earnings (P/E)N/A
Beta1.37
Next Earnings
May 09, 2024EPS Estimate
€0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding58,563,005
10 Day Avg. Volume5
30 Day Avg. Volume50
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)3.19
Price to Sales (P/S)1.02
Price to Cash Flow (P/CF)-4.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.90
Enterprise Value/Gross Profit1.83
Enterprise Value/Ebitda-2.65
Forecast
1Y Price Target
€11.61Price Target Upside123.24% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Health Catalyst News
PremiumCompany Announcements
Health Catalyst Executive Team Undergoes Major Reshuffle
Bulls Say, Bears Say
Bulls Say
Financial PerformanceHCAT's platform upgrades herald a brighter future with expectations of a stronger sales pipeline and enhanced dollar-based retention.
Market PositionPositive client feedback and a shift to a cloud-native environment position HCAT as an essential player in health system operations.
Product DevelopmentInnovative product demos of Pop Analyzer and AI Co-pilot showcase HCAT's potential to boost efficiency and advance strategic goals.
Bears Say
Growth Outlook2024 Growth Outlook Disappoints, with guidance for growth to be slower than the previous year.
Revenue Expectations2024 revenue guidance was well below analyst and consensus expectations.
Revenue Guidance2024 revenue guidance calls for just +4% y/y growth, which is below the previous expectations.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
2.45% Other Institutional Investors
97.55% Public Companies and
Individual Investors
2YP FAQ
What was Health Catalyst’s price range in the past 12 months?
Health Catalyst lowest stock price was €5.15 and its highest was €12.70 in the past 12 months.
What is Health Catalyst’s market cap?
Currently, no data Available
When is Health Catalyst’s upcoming earnings report date?
Health Catalyst’s upcoming earnings report date is May 09, 2024 which is in 14 days.
How were Health Catalyst’s earnings last quarter?
Health Catalyst released its earnings results on Feb 22, 2024. The company reported €0.019 earnings per share for the quarter, beating the consensus estimate of €0.011 by €0.008.
Is Health Catalyst overvalued?
According to Wall Street analysts Health Catalyst’s price is currently Undervalued.
Does Health Catalyst pay dividends?
Health Catalyst does not currently pay dividends.
What is Health Catalyst’s EPS estimate?
Health Catalyst’s EPS estimate is €0.03.
How many shares outstanding does Health Catalyst have?
Currently, no data Available
What happened to Health Catalyst’s price movement after its last earnings report?
Health Catalyst reported an EPS of €0.019 in its last earnings report, beating expectations of €0.011. Following the earnings report the stock price went down -7.186%.
Which hedge fund is a major shareholder of Health Catalyst?
Among the largest hedge funds holding Health Catalyst’s share is PRIMECAP Management Co. It holds Health Catalyst’s shares valued at 13M.
---
Health Catalyst Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€11.61 (123.24% Upside)
€11.61 (123.24% Upside)
Blogger Sentiment
Neutral
DE:2YP Sentiment 50%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $204.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-53.63%
12-Months-Change
Fundamentals
Return on Equity
-29.84%
Trailing 12-Months
Asset Growth
-6.71%
Trailing 12-Months
Company Description
Health Catalyst
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in Salt Lake City, UT.
---
2YP Earnings Call
Q4 2024
0:00 / 0:00
---
2YP Stock 12 Months Forecast
Average Price Target
€11.61
▲(123.24% Upside)
Technical Analysis
Best Analysts Covering 2YP
1 Year
1 Year Success Rate
5/24 ratings generated profit
1 Year Average Return
-28.08%
assigned a buy rating 2 months ago
Copying Stephanie Davis's trades and holding each position for 1 Year would result in 20.83% of your transactions generating a profit, with an average return of -28.08% per trade.
---